EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

NCT00114738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

NIH

Sponsor class

Conditions

Lymphoma, Mantle Cell
Mantle Cell Lymphoma

Interventions

DRUG: Rituximab (R)
BIOLOGICAL: EPOCH
DRUG: Bortezomib (B)
DRUG: Bortezomib
DRUG: Bortezomib or observation

Sponsor

National Cancer Institute (NCI)